Luceome Biotechnologies is an emerging, privately-held biotechnology company located in Tucson, Arizona. Luceome enables drug discovery by leveraging its assay technology for identification of drugs against kinases.
Luceome provides unique assay solutions (KinaseSeeker™ and KinaseLite™) to clients for meeting their selectivity profiling needs as well as for the development of assays against specific targets. Luceome's assays are based on a technology platform that utilizes luciferase fragment complementation. The resulting luminescence detection is sensitive with low background interference, allowing identification of target and off-target effects of drug candidates.